Oral Vaccines Market in-depth Research of the Oral Vaccines Marketstate and the competitive landscape globally. Analyses the important factors of the Oral Vaccines Market based on present industry situations, market demands, business strategies utilized by Oral Vaccines Market players and the future prospects from various angles in detail. The report also presents forecasts for Oral Vaccines Market from 2017 till 2022.
In this report, the global Oral Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales K Units, revenue Million USD, market share and growth rate of Oral Vaccines for these regions, from 2012 to 2022 forecast, covering
- United States
- Southeast Asia
Global Oral Vaccines market competition by top manufacturers/players, with Oral Vaccines sales volume, Price USD/Unit, revenue Million USD and market share for each manufacturer/player; the top players including
- GlaxoSmithKline Plc.
- PaxVax Corporation
- Pfizer Inc
- Merial, Inc.
- Merck Sharp & Dohme Corp
- VALNEVA Canada Inc.
- QUíMICA SUIZA S.A
- Immunitor, Inc
- Aventis Sanofi S.A.
- Serum Institute of India Pvt. Ltd
- Swiss Serum and Vaccine Institute Berne
- Bull Bio NCIPD Ltd.
- Vaxart, Inc.
- Shantha Biotechnics
- Crucell Janssen Global Services, LLC
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Live Attenuated Vaccines
- Killed/Inactivated Vaccines
- Recombinant Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Vaccines for each application, including
- Respiratory Infections
Table of Contents
Global Oral Vaccines Sales Market Report 2017
1 Oral Vaccines Market Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Classification of Oral Vaccines by Product Category
1.2.1 Global Oral Vaccines Market Size Sales Comparison by Type 20122022
1.2.2 Global Oral Vaccines Market Size Sales Market Share by Type Product Category in 2016
1.2.3 Live Attenuated Vaccines
1.2.4 Killed/Inactivated Vaccines
1.2.5 Recombinant Vaccines
1.3 Global Oral Vaccines Market by Application/End Users
1.3.1 Global Oral Vaccines Sales Volume and Market Share Comparison by Application 20122022
1.3.7 Respiratory Infections
2 Global Oral Vaccines Competition by Players/Suppliers, Type and Application
2.1 Global Oral Vaccines Market Competition by Players/Suppliers
2.1.1 Global Oral Vaccines Sales and Market Share of Key Players/Suppliers 20122017
2.1.2 Global Oral Vaccines Revenue and Share by Players/Suppliers 20122017
2.2 Global Oral Vaccines Volume and Value by Type
2.2.1 Global Oral Vaccines Sales and Market Share by Type 20122017
2.2.2 Global Oral Vaccines Revenue and Market Share by Type 20122017
2.3 Global Oral Vaccines Volume and Value by Region
2.3.1 Global Oral Vaccines Sales and Market Share by Region 20122017
2.3.2 Global Oral Vaccines Revenue and Market Share by Region 20122017
New York City Zone 01,
NY, United States.
International: (+1) 646 781 7170
UK (Toll free): +44 800 088 5734